Collegium Pharmaceutical, Inc. Common Stock (COLL) is a publicly traded Healthcare sector company. As of November 5, 2026, COLL trades at $24.83 with a market cap of $772.54M and a P/E ratio of 14.48. COLL moved +4.89% today. Year to date, COLL is -48.24%; over the trailing twelve months it is -33.88%. Its 52-week range spans $21.43 to $50.79. Analyst consensus is strong buy with an average price target of $48.71. Rallies surfaces COLL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
COLL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COLL recently traded at $24.83. Market cap is $772.54M. P/E ratio is 14.48. Revenue is $808.21M.
| Metric | Value |
|---|---|
| Price | $24.83 |
| Market Cap | $772.54M |
| P/E Ratio | 14.48 |
| EPS | $1.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.79 |
| 52-Week Low | $21.43 |
| Volume | 41 |
| Avg Volume | 0 |
| Revenue (TTM) | $808.21M |
| Net Income | $47.91M |
| Gross Margin | 60.02% |
7 analysts cover COLL: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.71.